Literature DB >> 24436572

Fatty acid metabolism and thyroid hormones.

Naomi L Sayre1, James D Lechleiter1.   

Abstract

The importance of thyroid hormone signaling in the acute regulation of metabolic activity has been recognized for decades. Slowly, the underlying mechanisms responsible for this activity are being elucidated. A prominent characteristic of thyroid signaling is rapid increases in oxygen consumption and ATP production. This discovery implicated a non-genomic regulation of mitochondrial metabolism by thyroid hormones. Another important clue came from the discovery that thyroid hormones stimulated fatty acid oxidation (FAO) in a variety of tissues in a receptor-dependent, but transcriptional-independent manner. Recently, key linkages between thyroid hormone signaling and specific mitochondrial-targeted pathways have been discovered. This review focuses on the molecular mechanisms by which mitochondrial FAO can be increased through thyroid hormone signaling. The roles of both the full-length and shortened mitochondrial isoforms of thyroid hormone receptor will be discussed. Additionally, the impact of thyroid hormone signaling on dyslipidemias such as obesity, type II diabetes, and fatty liver disease will be considered.

Entities:  

Keywords:  3,3,5 triiodothyronine; ACC; AMPK; CO23; CPT; GC-1; LCHAD; MB07344; MTP; T2; T3,3,5 diiodothyroinine; TRα; TRβ; acetyl-coA carboxylase; adenosine monophosphate activated protein-kinase; c-erbA; carnitine palmitoyl transferase; dyslipidemia; energy homeostasis; fatty acid; fatty acid oxidation; fatty acid trafficking; insulin resistance; long-chain acyl CoA dehydrogenase; metabolic syndrome; mitochondria; mitochondrial trifunctional protein; non-alcoholic fatty liver disease; non-genomic; obesity; p28; p30; p43; steatosis; thyroid hormone; thyroid hormone analogs; thyroid hormone receptor; thyrotoxicity; type II diabetes

Year:  2012        PMID: 24436572      PMCID: PMC3891511     

Source DB:  PubMed          Journal:  Curr Trends Endocinol        ISSN: 0972-947X


  87 in total

1.  Design and characterization of a thyroid hormone receptor alpha (TRalpha)-specific agonist.

Authors:  Cory A Ocasio; Thomas S Scanlan
Journal:  ACS Chem Biol       Date:  2006-10-24       Impact factor: 5.100

Review 2.  Cardiovascular involvement in patients with different causes of hyperthyroidism.

Authors:  Bernadette Biondi; George J Kahaly
Journal:  Nat Rev Endocrinol       Date:  2010-06-29       Impact factor: 43.330

3.  Expression of uncoupling protein-3 and mitochondrial activity in the transition from hypothyroid to hyperthyroid state in rat skeletal muscle.

Authors:  A Lanni; L Beneduce; A Lombardi; M Moreno; O Boss; P Muzzin; J P Giacobino; F Goglia
Journal:  FEBS Lett       Date:  1999-02-12       Impact factor: 4.124

4.  Non-receptor-mediated actions are responsible for the lipid-lowering effects of iodothyronines in FaO rat hepatoma cells.

Authors:  Elena Grasselli; Adriana Voci; Laura Canesi; Fernando Goglia; Silvia Ravera; Isabella Panfoli; Gabriella Gallo; Laura Vergani
Journal:  J Endocrinol       Date:  2011-04-20       Impact factor: 4.286

Review 5.  Biochemical basis of thyroid hormone action in the heart.

Authors:  W H Dillmann
Journal:  Am J Med       Date:  1990-06       Impact factor: 4.965

6.  Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins.

Authors:  C V Dang; W M Lee
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

Review 7.  Molecular aspects of thyroid hormone actions.

Authors:  Sheue-Yann Cheng; Jack L Leonard; Paul J Davis
Journal:  Endocr Rev       Date:  2010-01-05       Impact factor: 19.871

8.  Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.

Authors:  Elisa Fabbrini; Faidon Magkos; B Selma Mohammed; Terri Pietka; Nada A Abumrad; Bruce W Patterson; Adewole Okunade; Samuel Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

Review 9.  Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters.

Authors:  Joost J F P Luiken; Susan L M Coort; Debby P Y Koonen; Dick J van der Horst; Arend Bonen; Antonio Zorzano; Jan F C Glatz
Journal:  Pflugers Arch       Date:  2004-02-10       Impact factor: 3.657

10.  Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats.

Authors:  Andrea Perra; Gabriella Simbula; Michela Simbula; Monica Pibiri; Marta A Kowalik; Pia Sulas; Maria T Cocco; Giovanna M Ledda-Columbano; Amedeo Columbano
Journal:  FASEB J       Date:  2008-04-23       Impact factor: 5.191

View more
  9 in total

1.  Insulin-inducible THRSP maintains mitochondrial function and regulates sphingolipid metabolism in human adipocytes.

Authors:  Maria A Ahonen; Marcus Höring; Van Dien Nguyen; Sami Qadri; Juuso H Taskinen; Meghana Nagaraj; Martin Wabitsch; Pamela Fischer-Posovszky; You Zhou; Gerhard Liebisch; P A Nidhina Haridas; Hannele Yki-Järvinen; Vesa M Olkkonen
Journal:  Mol Med       Date:  2022-06-17       Impact factor: 6.376

Review 2.  Transport of thyroid hormones via the choroid plexus into the brain: the roles of transthyretin and thyroid hormone transmembrane transporters.

Authors:  Samantha J Richardson; Roshen C Wijayagunaratne; Damian G D'Souza; Veerle M Darras; Stijn L J Van Herck
Journal:  Front Neurosci       Date:  2015-03-03       Impact factor: 4.677

3.  Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance.

Authors:  Noelia Martínez-Sánchez; Patricia Seoane-Collazo; Cristina Contreras; Luis Varela; Joan Villarroya; Eva Rial-Pensado; Xabier Buqué; Igor Aurrekoetxea; Teresa C Delgado; Rafael Vázquez-Martínez; Ismael González-García; Juan Roa; Andrew J Whittle; Beatriz Gomez-Santos; Vidya Velagapudi; Y C Loraine Tung; Donald A Morgan; Peter J Voshol; Pablo B Martínez de Morentin; Tania López-González; Laura Liñares-Pose; Francisco Gonzalez; Krishna Chatterjee; Tomás Sobrino; Gema Medina-Gómez; Roger J Davis; Núria Casals; Matej Orešič; Anthony P Coll; Antonio Vidal-Puig; Jens Mittag; Manuel Tena-Sempere; María M Malagón; Carlos Diéguez; María Luz Martínez-Chantar; Patricia Aspichueta; Kamal Rahmouni; Rubén Nogueiras; Guadalupe Sabio; Francesc Villarroya; Miguel López
Journal:  Cell Metab       Date:  2017-07-05       Impact factor: 27.287

4.  Culture in Glucose-Depleted Medium Supplemented with Fatty Acid and 3,3',5-Triiodo-l-Thyronine Facilitates Purification and Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Bin Lin; Xianming Lin; Maxine Stachel; Elisha Wang; Yumei Luo; Joshua Lader; Xiaofang Sun; Mario Delmar; Lei Bu
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-09       Impact factor: 5.555

Review 5.  The Swing of Lipids at Peroxisomes and Endolysosomes in T Cell Activation.

Authors:  Sara G Dosil; Amelia Rojas-Gomez; Francisco Sánchez-Madrid; Noa B Martín-Cófreces
Journal:  Int J Mol Sci       Date:  2020-04-19       Impact factor: 5.923

Review 6.  Metabolic and Energy Imbalance in Dysglycemia-Based Chronic Disease.

Authors:  Sanjay Kalra; Ambika Gopalakrishnan Unnikrishnan; Manash P Baruah; Rakesh Sahay; Ganapathi Bantwal
Journal:  Diabetes Metab Syndr Obes       Date:  2021-01-15       Impact factor: 3.168

7.  Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.

Authors:  Po-Yu Lin; Wen-Chen Liang; Wei-An Liao; Yuan-Ting Sun
Journal:  BMC Neurol       Date:  2021-02-27       Impact factor: 2.474

Review 8.  Gut hormone polyagonists for the treatment of type 2 diabetes.

Authors:  Sara J Brandt; Anna Götz; Matthias H Tschöp; Timo D Müller
Journal:  Peptides       Date:  2018-02       Impact factor: 3.750

Review 9.  The role of thyroid hormone in metabolism and metabolic syndrome.

Authors:  Patrícia de Fátima Dos Santos Teixeira; Patrícia Borges Dos Santos; Carmen Cabanelas Pazos-Moura
Journal:  Ther Adv Endocrinol Metab       Date:  2020-05-13       Impact factor: 3.565

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.